Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma
Author(s) -
Chang Dong,
Yong Cui,
Bingqun Wu,
Xinchun Duan,
Guan Shi,
Min Gong,
Tianyou Wang
Publication year - 2015
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.163838
Subject(s) - epidermal growth factor receptor , esophageal squamous cell carcinoma , vascular endothelial growth factor , cyclooxygenase , growth factor receptor inhibitor , vascular endothelial growth factor c , cancer research , basal cell , epidermal growth factor , vascular endothelial growth factor a , vegf receptors , medicine , carcinoma , receptor , oncology , biology , enzyme , biochemistry
Esophageal squamous cell carcinoma (ESCC) is a frequently occurring cancer with poor prognosis despite combined therapeutic strategies. The aim of the current study was to elucidate a further finding on the clinicopathologic significance of immunohistochemical expression of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF), and epidermal growth factor receptor (EGFR) in Chinese patients with ESCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom